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Abstract
Age-related cataract is a major cause of blindness worldwide, and cortical cataract is the second most prevalent type of age-
related cataract. Although a significant fraction of age-related cataract is heritable, the genetic basis remains to be
elucidated. We report that homozygous deletion of Epha2 in two independent strains of mice developed progressive
cortical cataract. Retroillumination revealed development of cortical vacuoles at one month of age; visible cataract appeared
around three months, which progressed to mature cataract by six months. EPHA2 protein expression in the lens is spatially
and temporally regulated. It is low in anterior epithelial cells, upregulated as the cells enter differentiation at the equator,
strongly expressed in the cortical fiber cells, but absent in the nuclei. Deletion of Epha2 caused a significant increase in the
expression of HSP25 (murine homologue of human HSP27) before the onset of cataract. The overexpressed HSP25 was in an
underphosphorylated form, indicating excessive cellular stress and protein misfolding. The orthologous human EPHA2 gene
on chromosome 1p36 was tested in three independent worldwide Caucasian populations for allelic association with cortical
cataract. Common variants in EPHA2 were found that showed significant association with cortical cataract, and rs6678616
was the most significant in meta-analyses. In addition, we sequenced exons of EPHA2 in linked families and identified a new
missense mutation, Arg721Gln, in the protein kinase domain that significantly alters EPHA2 functions in cellular and
biochemical assays. Thus, converging evidence from humans and mice suggests that EPHA2 is important in maintaining lens
clarity with age.
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Introduction
Cataract is the leading cause of visual impairment worldwide,
with approximately 37 million people affected, accounting for
48% of global blindness [1]. Cataract is defined as any opacity of
the crystalline lens resulting from either alteration in lens cell
structure or changes in lens proteins or both. Morphologic
classification of age-related cataract can be divided into four
categories: nuclear, cortical, posterior subcapsular cataract and
mixed type. Among Caucasian Americans aged 65 years or older,
the reported prevalence of cortical cataract was 24% [2].
Incidence of cataract surgery in the United States is highest
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14% [3].
Age-related cataract has consistently been attributed to risk
factors such as old age, female gender, diabetes, hypertension,
smoking, UV light exposure, and heavy alcohol intake [4]. Recent
studies showed excess clustering of disease in families [4].
Heritability for cortical cataract in female twins was estimated as
high as 58%, and at least 11% of total variance was accounted for
by age [5]. In segregation analysis in the Beaver Dam Eye Study
(BDES), a single major gene accounted for 58% of the variability
of age- and gender-adjusted measures of cortical cataract [6].
Genes involved in the oxidative stress pathway [7], hypergalacto-
semia [8], hyperferritinemia [9], diabetic complications [10], and
neurodegenerative disease [11,12], mediate development of
juvenile or age-related cataract.
A genome-wide scan for cortical cataract after adjusting for
covariates in a subset of the BDES showed evidence of linkage in
1p36 [13]. This region is one of the most replicated loci for
inherited cataract including the Volkman (pulverulent) cataract
from a large Danish pedigree [14], a type of posterior polar
cataract [15], and a total congenital cataract from a six-generation
Australian family [16]. The Eph receptor A2 gene (EPHA2) that
resides under the linkage peak on 1p36 was selected as a candidate
gene because knockout mice for Epha2 developed age-related
cortical cataract. In this study, we extensively examined charac-
teristics of the EPHA2 protein using knockout mice. We
investigated allelic association by re-sequencing and genotyping
of single nucleotide polymorphisms (SNPs) in coding and non-
coding conserved regions in large population-based human
studies.
Results
Epha2 Knockout Mice Developed Progressive Cortical
Cataract
During the course of characterizing mice with deletion of
Epha2 gene, we observed development of progressive cortical
cataract in a significant fraction of homozygous knockout mice.
This line of knockout mice (Epha2
2/2) with deletion of exons 6–
17 was generated using a secretory gene trapping strategy
[17,18]. Initially noticed on FVB/NJ genetic background, visible
bilateral lens opacity in Epha2
2/2 mice appeared by five months,
which was confirmed as cataract by slit lamp examination
(Figure 1A). The incidence and severity increased with age,
affecting over 80% of mice by 12 months (Table 1). Inspection of
dissected lens revealed significant lens opacity between three to
four months, and mature cataracts with lens rupture occurred
between six to eight months (Figure 1B and Figure S1A). Dense
opacity initiated around the equator and progressed to involve
t h ee n t i r el e n s( F i g u r e1 B ) .A searly as one month after birth,
prior to the onset of lens opacity, retroillumination examination
revealed clusters of subcapsular vacuoles in the anterior cortex of
the Epha2 knockout but not in heterozygous or wild-type lenses
(Figure 1C), which are indicative of structural and osmotic
alterations in the lens [19].
To further confirm a link between loss of Epha2 gene and
cataractogenesis, we examined another Epha2 mutant mouse line
on C57Bl/6 genetic background, where a retrovirus is inserted in
the first intron, inactivating expression of Epha2 [20]. The
homozygous mutant mice developed cataracts with similar
morphological changes as the secretory gene trapping mice on
FVB/NJ background described above. Thus, neither the strain
genetic backgrounds nor the secretory trapping of partial EPHA2
ectodomain fused to b-gal is likely to be a major contributing
factor in the lens phenotypes of the Epha2 mutant mice.
Interestingly, in cohorts of mice subject to two-stage chemical
skin carcinogenesis studies [17], the penetrance of cataract
increased to 100% by six months, suggesting that similar to
humans, environmental factors could significantly influence
cataractogenesis in Epha2-null mice.
EPHA2 Protein Is Expressed in Mice and Human Lens
We found that EPHA2 was expressed in lens homogenates of
wild type mice, and the level of expression progressively decreased
with age (Figure 1D). The relative level of expression is compatible
with other tissues known to have high levels of EPHA2 such as the
skin [17]. Immunofluorescence analysis revealed that EPHA2 was
most abundantly expressed in cortical lens fiber cells but not
nuclear fiber cells (Figure 1E). In lens epithelial cells, EPHA2
expression was low in the anterior region and became upregulated
when epithelial cells underwent differentiation at the lens equator
(Figure 1E–1K). Much weaker staining was seen in the nuclei of
the lens. To verify these findings, we separated lens cortex and
nuclei from two week and five month old mice and subjected the
homogenates to immunoblot. EPHA2 was highly expressed in
cortical fiber cells at two weeks, which fell significantly by five
months (Figure S1F). Histochemical staining for LacZ reporter
gene cassette confirmed the elevated EPHA2 expression near the
equator (Figure S1). Consistent with our observations in the
mouse, EPHA2 was readily detectable in human lens fiber cells by
immunoblot and immunohistochemistry (Figure S2).
Eph kinases bind to membrane-anchored ligands called ephrins
and mediate cell contact-dependent bidirectional signaling
[21,22]. We found that ephrin-A1, a ligand for EPHA2, displayed
a similar expression pattern with strong expression in lens fiber
cells as well as lens epithelial cells near the equator (Figure 2A and
2B). The expression of EPHA2 and ephrin-A1 in the overlapping
regions suggests EPHA2-ephrin-A1 interaction at these sites,
which could have signaling and/or structural roles in the lens.
Homozygous deletion of Epha2 gene led to significant alteration in
ephrin-A1 localization (Figure 2C and 2D) concomitant with
changes in lens structures (Figure 2D). Staining for expression of
N-cadherin (Figure 1L and 1M), a known component of cell
adhesion junctions in lens fiber cells, further confirmed structural
defects in the mutant lens (Figure 2E and 2F).
Author Summary
Cataract is the leading cause of blindness. Cataract may
form at any age, but the peak incidence is bimodal—in the
perinatal period or later than 50 years of age. The early
onset forms follow Mendelian inheritance patterns and are
rare. Age-related cataract accounts for 18 million cases of
blindness and 59 million cases of reduced vision world-
wide. Among three types of age-related cataract, cortical
cataract is known to be highly heritable, although few
genes have been linked to its etiology. We report here that
EPHA2 is associated with cortical cataract. EPHA2 is
expressed in mouse and human cortical lens fiber cells,
and homozygous deletion of Epha2 in two independent
strains of mice led to development of cataract that
progressed with age. Common and rare variants including
a missense mutation in the EPHA2 gene were associated
for cortical cataract in three different Caucasian popula-
tions. Our study identified EPHA2 as a gene for human age-
related cataract and established Epha2 knockout mice as a
model for progressive cortical cataract.
EPHA2 in Age-Related Cortical Cataract
PLoS Genetics | www.plosgenetics.org 2 July 2009 | Volume 5 | Issue 7 | e1000584Figure 1. Development of progressive cataract in Epha2 knockout mice and characterization of spatial and temporal regulation of
EPHA2 expression in the lens. (A–C) Epha2 homozygous deletion in mice causes development of progressive cataract. (A) Cataracts were visible
by gross inspection in homozygous Epha2 knockout mice (Epha2
2/2) between 5 to 8 months of age, but not in heterozygous or wild type mice.
Shown are slit lamp images confirming development of cataract in Epha2
2/2 but not Epha2
+/+ mice. (B) Dark field imaging of the dissected lens.
Although not readily detectable by visual inspection, cataracts were found on dissected lens by 3 months of age. This lens was tilted to show denser
opacity near the equator (arrow). Enucleation frequently occurred during dissection of mature cataract after 8 months (far right). (C) Retroillumination
examination revealed clusters of small vacuoles by one month of age. Scale bars: 1 mm for middle panel; 150 mm for right panel. (D) Immunoblot of
total lens lysates showing decreasing EPHA2 expression with aging. (E–M) Compartmentalized and gradient expression of EPHA2 (red) in mouse lens.
Blue: DAPI nuclear staining. (E–I) Midsagittal sections of lens from 14-day-old wild type mice were stained for EPHA2. (E) Low power view of an entire
lens revealed dense expression of EPHA2 in subcortical lens fiber cells. Dotted arrows indicate gradient expression in lens epithelial cells near the
equator. Scale bar: 1 mm. (F) Low EPHA2 expression in anterior lens epithelial cells (arrow head, sandwiched between dotted lines). (G) Inset from (F)
showing high EPHA2 expression in lens fiber cells. (H) High level of EPHA2 expression at the bow. (I) Inset from (H) showing dense expression at
modulus (arrow). Scale bars: 5 mm for F–I. (J–M) Coronal sections through the bow region of lens co-stained for EPHA2 and N-cadherin. (J) Note the
spatially regulated expression pattern in subcortical lens fiber cells. (K) Inset from (J) showing ‘‘honey-comb’’ membrane staining pattern of EPHA2 in
the cross sections of fiber cells at high magnifications. (L) N-cadherin from the same section show overlapping but distinct expression pattern
compared with that of EPHA2. (M) Merged images of EPHA2/N-cadherin. 10 mm for J, L, and M; 2 mm for K.
doi:10.1371/journal.pgen.1000584.g001
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2/2 Mouse Lens
Disruption of lens structure could be caused by cellular
stresses. We found that HSP25, a small heat shock protein and
the murine homologue of human HSP27, was significantly
overexpressed in the Epha2 knockout lens from day two after
birth, long before the onset of cataract (Figure 2G–2I).
Expression of HSP90, on the other hand, was not affected. Prior
to the onset of lens degeneration at old age (6 months and
beyond), expression of major crystallins did not show significant
change either (Figure S3A). HSP25 is closely related to and
directly interacts with aB-crystallin, being expressed during
oxidative stress in human cataractous lenses [21]. The overex-
pressed HSP25 in mutant lenses is in an underphosphorylated
form that is known to form large aggregates with misfolded
proteins (Figure 2J) [23,24]. By trapping misfolded proteins in
large aggregates, HSP25 could contribute to cataractogenesis.
While the exact mechanisms of cataractogenesis remain to be
fully elucidated, these results together suggest that Epha2 deletion
probably causes elevated stress responses in the lens, which may
lead to increased protein misfolding, cellular structural damages
and eventual lens opacity.
Identification of Coding Variants in Humans Using Re-
Sequencing
The human EPHA2 gene is located on 1p36 where we and others
had previously reported linkage with cortical and progressive
juvenile onset cataract, respectively [13–16]. This, together with the
Epha2 knockout mouse data described above, motivated us to
investigate association between cortical cataract and EPHA2 in
humans. For discovery, we used a population-based family sample
from the US Beaver Dam Eye Study (BDES) cohort (Table 2),
which was initially used for linkage analysis of cortical cataract [13].
To select individuals for re-sequencing, we identified families linked
to markers on 1p36 from our previous set. We re-sequenced all 17
exons and intron-exon boundaries of EPHA2 in 34 individuals from
the linked families (Table S1). We identified four new coding
variants (Ser74Ser, Arg721Gln, Lys728Lys, and Ile779Ile) and one new
non-coding variant (A/G in intron 12-13) (Table 3). These variants
were rare (minor allele frequency MAF,1%) and have never been
reported before. We also confirmed one non-coding insertion-
deletion polymorphism (rs35519704: -/G) and seven other coding
variants, including rs6678618 (Ala190Ala), rs6678616 (Leu191Leu),
rs35484156 (Ser277Leu), rs2230597 (Pro329Pro), rs55655135
(Leu632Leu), rs10907223 (Leu661Leu), and rs3754334 (Ile958Ile).
These polymorphisms were previously reported in public databases.
Among variants identified via re-sequencing, two non-synony-
mous variants (Arg721Gln and rs35484156) and two synonymous
variants (Ile779Ile and rs6678616) were pursued by genotyping all
available individuals (Table 4) in the discovery BDES set (494
families, N=1401). The Arg721Gln variant demonstrated the
strongest association (P values: cortical=2610
28, severe corti-
cal=8610
25) in the BDES. We performed extensive quality
control metrics for the final model containing Arg721Gln in the
discovery dataset to confirm both the consistency and the validity
of the association result (Figure S4). We did not discover any bias
in the SNP association caused by other factors.
The risk allele for Arg721Gln was the rare ‘A’ allele (Table 5). We
estimated that after adjusting for covariates the risk allele for
Arg721Gln can cause a net increase in the cortical score of 9.2%
under the dominant model (i.e. if an individual carries one ‘A’
allele for the Arg721Gln variant, the cortical cataract score
increases by 9.2% compared to carrying ‘GG’ alleles). Since we
did not have Arg721Gln ‘AA’ homozygotes in our data, we did not
assess the effect size for a recessive model. Using the severe cortical
cataract trait the association signal at Arg721Gln was less significant
(Table 5), showing that smaller sample sizes led to reduced power.
The sequencing data for Arg721Gln confirmed that the risk allele
‘A’ segregates with disease in a BDES family (Figure 3). We were
unable to investigate segregation for heterozygous individuals in
the other families, because missing data caused these individuals to
be singletons or unconnected. We also genotyped the Arg721Gln
variant in two replication datasets (Table 2), the United Kingdom
Twin Eye Study (UKTS; 185 individuals from 172 families) and
the Australian Blue Mountains Eye Study comprising unrelated
persons (BMES; N=1470). The three datasets were comparable
with respect to measurement of the trait and the way the data were
defined for analysis (Figure S5). The frequency of the rare ‘A’ allele
is 0.6%, 0% and 0.2% in the BDES, UKTS, and BMES,
respectively. These frequencies are not significantly different in the
BMES and UKTS (Table S2); increased frequency of the ‘A’ allele
in the BDES was probably due to enrichment of the same risk
allele in these families (i.e. a founder effect), and we believe that
0.1%–0.2% represents a true population estimate for this rare
variant. The risk allele has 78% penetrance in heterozygous
individuals whose age is 70 years or more. We were unable to test
association for the Arg721Gln in the replication sets because either
the rare allele was not present (UKTS) or its frequency was too
small (BMES) to be used in the statistical models.
Biochemical and Cellular Characterization of the Non-
Synonymous Variant Arg721Gln
Functionally, the Arg721Gln mutation changes arginine, a
positively charged amino acid, to glutamine. Examination of the
EPHA2 kinase domain crystal structure [25] revealed that Arg721
in the aE helix forms a salt bridge with Asp872 in the aI helix
(Figure 4A). Interestingly, both Arg721 and Asp872 are concor-
dantly conserved among different members of human Eph kinases
and among EPHA2 proteins across different species (Figure 4B
and 4C). The Arg721Gln mutation may disrupt the salt bridge and
affect its conformation and function. To test this possibility, wild
type (WT) and Arg721Gln mutant EPHA2 were expressed in HEK
293 cells that have low endogenous EPHA2 [26]. Although the
mutant receptor still remained responsive to ligand stimulation in
both kinetic and dose-response studies (Figure 5A and 5B), it
displayed significantly higher basal activation than WT-EPHA2 in
the absence of ligand stimulation. Consistent with our previous
report that activated EPHA2 inhibited the Ras/ERK1/2 signaling
cascade [26], the higher basal activation of EPHA2 was correlated
with dramatically reduce basal ERK1/2 activities compared to
Table 1. Incidence of Visible Cataracts in Wild-Type and
Epha2-null Mice.
Age of
animal
Equivalent
human age Incidence of cataracts (%)
+/++ /22 /2
2 months 5 years 0 (0/6) 0 (0/6) 0 (0/6)
5 months 18 years 0 (0/9) 0 (0/15) 26.1 (6/23)
6 months 20 years 0 (0/10) 0 (0/15) 52.6 (10/19)
8 months 28 years 0 (0/18) 0 (0/27) 73.5 (36/49)
14 months 40 years 0 (0/14) 0 (0/23) 83.3 (15/18)
Note: Cataract development was determined by visual inspection every two
weeks. Microscopic examination of the dissected lens showed cataract occurred
as early as three months of age (see Figure 1B).
doi:10.1371/journal.pgen.1000584.t001
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mutant EPHA2. In a clonal growth assay, HEK 293 cells
expressing Arg721Gln-EPHA2 were significantly growth-inhibited
cells by ephrin-A1, whereas WT-EPHA2 expressing cells were
refractory (Figure 5C). In addition, we observed stochastic
intracellular retention of the Arg721Gln mutant EPHA2, but not
Figure 2. Structural alteration and stress responses in Epha2
2/2 lens. (A–D) Expression of ephrin-A1, a ligand for EPHA2. Note the
disorganized ephrin-A1 expression and formation of vacuoles in the Epha2
2/2 lens (arrow heads). Scale bars: 1 mm for A and C; 10 mm for B and D.
(E,F) N-cadherin staining showing disorganization of lens fiber cells. Scale bars: 5 mm. (G) Overexpression of HSP25 but not HSP90 in Epha2
2/2 lens
which was quantified in (H), and confirmed by immunofluorescence staining (I). Scale bars: 40 mm. (J) Immunoblot for phosphorylated HSP25
revealed relatively low degree of phosphorylation in Epha2
2/2 lens.
doi:10.1371/journal.pgen.1000584.g002
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(MEF) cells derived from Epha2
2/2 embryos, affecting about
40% of total cell populations (Figure 5D). The effects were cell
type-specific, as they were not observed in HEK 293 cells. While
the molecular mechanism for the cytosolic retention is unclear at
present, the data in aggregate demonstrate that the Arg721Gln
mutation significantly alters EPHA2 signaling and cellular
regulation in vitro. Because EPHA2 is essential in maintaining
lens clarity in the mouse knockout model (Figure 1), it is possible
that such perturbation of EPHA2 functions by the Arg721Gln
mutation can predispose the carrier to cataractogenesis. Further
studies, including knock-in of the mutant allele in mice, will be
necessary to determine if the mutation is sufficient to predispose to
lens opacity in vivo.
Identification of Common Variants Associated with Age-
Related Cortical Cataract
In order to find common variants associated with disease, we
selected 15 SNPs based on tagging parameters and phylogenetic
conservation (Figure 6A–6C) in addition to 4 coding variants
identified via re-sequencing, resulting in 19 additional SNPs that
covered at least 90% of the gene (Table 4). We genotyped these
SNPs in three worldwide Caucasian populations (Table S2).
Genotyping in all three datasets demonstrated that the EPHA2
gene contained at least two blocks of linkage disequilibrium (LD),
one at the 59 and another at the 39 end that were relatively
independent; the LD in the BDES, BMES, and UKTS was very
similar to that in the CEU HapMap sample (Figure S6). The
markers within each block are highly correlated, while those
between the 59 and 39 blocks show low correlation (Figure S6).
The highest pairwise correlation (r
2) between SNPs in 59 and 39
LD blocks did not exceed 0.5 in all three datasets (Figure S6).
We performed association analyses using percent of lens affected
with cortical cataract as a dependent variable. We also tested
association using affection status only, classifying individuals as clearly
affected (percent of cortical score $25) or unaffected (percent of
cortical score ,1), and eliminating all those with intermediate scores.
If the whole range of scores was considered, the average cortical score
in the BDES, UKTS, and BMES was 7.6%, 16.3%, and 3.2%,
respectively, while the proportions with severe cortical cataract in the
BDES, UKTS, and BMES were 10%, 29%, and 3%, respectively.
Prior to association analysis, the quantitative trait of percent of lens
Table 2. Phenotypic characteristics of the BDES, BMES, and UKTS samples used for genotyping.
Study and Covariate Cortical Severe Cortical
a
UA AFF
BDES
Total, N 1401 495 142
Average age at baseline (years) 64 (11.0) 61 (10.8) 70 (8.3)
Gender (% of female) 54.7 48.1 69.7
% of ever smokers 54.0 59.0 52.1
% of history of heavy drinkers 25.7 26.8 16.4
% of history of diabetes 16.0 12.0 19.0
Average body mass index (kg/cm2) 30.3 (5.8) 30.2 (5.9) 29.7 (5.7)
Average of age-related macular degeneration score 4.8 (3.2) 4.1 (2.7) 5.6 (3.5)
Average cortical cataract score (0–100%) 7.6 (11.9) 0.5 (0.3) 38.1 (12.1)
UKTS
Total, N 185 103 53
Average age at baseline (years) 65 (4.5) 64 (3.7) 66 (4.9)
Gender (% of female) 100.0 100.0 100.0
% of ever smokers 44.3 46.6 39.6
Average alcohol intake 1.9 (1.1) 1.8 )1.2) 2.0 (1.0)
Average systolic blood pressure 132 (19) 129 (17) 137 (22)
Average cortical cataract score (0–100%) 16 (23.2) 0.0 (0.0) 47.8 (18.5)
BMES
Total, N 1470 400 52
Average age (years) 64 (8.2) 70 (8.4) 72 (7.2)
Gender (% of female) 43.3 49.8 26.9
% of ever smokers 49.3 50.3 36.5
% of hypertension 54.1 59.2 63.5
Average systolic blood pressure 149 (21) 151 (21) 154 (20)
Average of age-related macular degeneration score 8.2 (2.7) 7.5 (2.9) 7.0 (3.0)
Average cortical cataract score (0–100%) 3.2 (7.6) 0.1 (0.1) 34.7 (9.4)
Values are given as mean (standard deviation [SD]) when appropriate.
aSevere cortical cataract represents a binary trait with a cutoff cortical score 25% for affected and with cortical scores,1% for unaffected in BDES, BMES, and UKTS.
Severe cortical cataract is a subset of the cortical cataract phenotype. UA: unaffected; AFF: affected.
doi:10.1371/journal.pgen.1000584.t002
EPHA2 in Age-Related Cortical Cataract
PLoS Genetics | www.plosgenetics.org 6 July 2009 | Volume 5 | Issue 7 | e1000584affected and the binary trait, affected with cataract (yes/no), were
adjusted for significant covariates using regression. The values
obtained after regression (residuals) were inverse rank transformed
to normalize their distribution. Association testing was performed on
values of the trait before and after inverse rank transformation.
Multiple genetic models (additive, dominant, and recessive) were
tested for each SNP (Table S3 and Table S4), but for brevity only the
dominant models are presented in the main text (Figure 6 and
T a b l e5 ) ;t h er e m a i n d e ro ft h em o d e l sa r ep r e s e n t e di nt h e
supplementary materials. In the discovery family data, six SNPs,
rs924201, rs7548209, rs11260721, rs3768293, rs6603867 and
rs6678616 showed significant association (nominal P,4.4610
24,
calculatedas 0.05 divided by 3 models62traits 619genotypedSNPs),
either with the full range of cortical cataract scores or with severe
cortical cataract. Except for rs6678616, P values at the other five
SNPs (rs924201, rs7548209, rs11260721, rs3768293 and rs6603867)
Table 4. Characteristics of SNPs in the EPHA2 gene.
SNP Position Context Alleles MA RA MAF Platform Selection Criterion
rs924201 16,318,936 Downstream G/A A A 0.383 SNPlex Non-coding conserved
rs7548209 16,321,209 Downstream G/C G C 0.333 SNPlex Non-coding conserved
rs1803527 16,324,000 39UTR T/C C C 0.017 SNPlex Non-coding conserved
rs3754334 16,324,354 Exon17-Syn G/A A A 0.292 TaqMan Tag-based
rs11260721 16,327,639 Intron 16-17 G/A G G 0.188 SNPlex Non-coding conserved
Ile779Ile 16,330,598 Exon 14 C/T T T 0.019* TaqMan Re-sequencing
Arg721Gln 16,331,308 Exon 13 G/A A A 0.003* TaqMan Re-sequencing
rs13375644 16,334,420 Intron 6-7 G/A A A 0.092 SNPlex Non-coding conserved
rs2230597 16,337,260 Exon5-Syn G/A A A 0.412 TaqMan Tag-based
Ser277Leu 16,337,506 Exon 4 C/T T T 0.005* TaqMan Re-sequencing
rs11260745 16,338,590 Intron3-4 A/G G G 0.085 SNPlex Non-coding conserved
rs3768293 16,340,511 Intron3-4 G/T G G 0.367 TaqMan Tag-based
rs6603867 16,347,288 Intron3-4 T/C T C 0.375 TaqMan Non-coding conserved
rs6678616 16,347,710 Exon3 G/A A A 0.333 SNPlex Re-sequencing
rs1472408 16,351,241 Intron2-3 C/T C T 0.367 SNPlex Non-coding conserved
rs6603883 16,355,563 Promoter C/T T T 0.358 SNPlex Non-coding conserved
rs11260822 16,358,398 Upstream G/A A A 0.356 SNPlex Non-coding conserved
rs904106 16,359,380 Upstream C/T T T 0.017 TaqMan Tag-based
rs729402 16,361,693 Upstream A/G A G 0.393 SNPlex Non-coding conserved
Positions are based on NCBI Build 36.3; alleles shown are on the coding strand (- strand); MA: minor alleles; RA: reference alleles that were used in genetic models for
association tests; MAF: minor allele frequency in dbSNP database; cells with asterisks (*) represent simple average MAF estimated from the three samples, the BDES,
BMES, and UKTS.
doi:10.1371/journal.pgen.1000584.t004
Table 3. Variants identified through re-sequencing.
Region RS# or Amino Acid Change Position
a SNP Type Alleles Amino Acid Change
Exon 3 Ser74Ser 16,348,061 Synonymous T/A S74S
rs6678618 16,347,713 Synonymous G/A A190A
rs6678616 16,347,710 Synonymous G/A L191L
Intron 3-4 rs35519704 16,347,431 Boundary of Exon 3 -/G -
Exon 4 rs35484156 16,337,506 Non-synonymous C/T S277L
Exon 5 rs2230597 16,337,260 Synonymous C/T P329P
Exon 11 rs55655135 16,332,419 Synonymous G/A L632L
rs10907223 16,332,332 Synonymous C/T L661L
Intron 12-13 - 16,331,400 Boundary of Exon 12 A/G -
Exon 13 Arg721Gln 16,331,308 Non-synonymous G/A R721Q
Lys728Lys 16,331,137 Synonymous G/A K728K
Exon 14 Ile779Ile 16,330,598 Synonymous C/T I779I
Exon 17 rs3754334 16,324,354 Synonymous G/A I958I
aPositions are based on NCBI Build 36.3.
doi:10.1371/journal.pgen.1000584.t003
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cataract, despite the decrease in sample size (Table 5). Differences in
the ability to detect association as a result of changed in phenotypic
definition are not unexpected, as association is dependent on allele
frequency, as well as on sample size.
Because the average cortical cataract score of the cases in the
UKTS was 10% greater than the other two studies, the proportion
of severe cases in the UKTS is 3 times and 10 times higher than
that in the BDES and BMES, respectively (Table 2). Thus, in the
replication dataset from the UKTS, P values for the severe cortical
cataract trait were in general smaller than the full range of cortical
cataract scores (Figure 6). Four of the same common SNPs
observed in the BDES, rs7548209, rs3754334, rs3768293, and
rs6678616, showed replication (smallest P value with
rs3754334=1610
24). In the UKTS we also identified significant
association for severe cortical cataract with another rare variant
Ile779Ile (P=3610
25). Rigorous diagnostic testing of the final
models in the two family datasets (BDES and UKTS) confirmed
that the results were valid (Figure S4).
Association Analysis of Common Variants in Unrelated
Data
We conducted single SNP and haplotype association analyses in
the BMES (Table S5). As the BMES cohort is slightly younger, if we
selected an age-matched case-control set, restricting controls to 70
years or greater, and defining cases as those with a cortical
score$25% and controls with cortical score,1% (Table 5) we
observed replication using the trend test (best P value at
rs7548209=0.003). Without these restrictions, the association was
less significant because the chance of misclassifying disease is higher
at younger ages (Table 5). Using the five most significant SNPs,
rs7548209, rs3754334, rs3768293, rs6603867 and rs6678616, we
performed a haplotype association test for cortical cataract using a
moving window approach with different window sizes from 2 to 5.
Haplotype analyses showed stronger evidence than single marker
tests in the BMES (Table 5). Three haplotypes showed significant
association at a nominal P,0.05 with window size 2 (Table 5). The
most significant haplotype encompassed rs6603867-rs6678616
(r
2=0.7) with C-A as the risk haplotype (b=6.6, P=1610
26)a n d
explained 6% of the total variance in cortical cataract scores. This
result was consistent with the single SNP association tests in the two
family studies (Figure 6E). The next best association is with C-G as
the risk haplotype (b=2.4, P=0.0024) and G-G as the protective
haplotype (b=20.7, P=0.020) at markers rs7548209-rs3754334
(r
2=0.8), suggesting that the‘C’allele at rs7548209 causesincreased
risk; this haplotype explained 2% of the variance in the quantitative
trait for cortical cataract. In total, these haplotypes accounted for
8% of the total variation. The risk alleles in the haplotype
association test above are similar to those in the single SNP
association in the two family datasets (Table 5).
Heterogeneity Tests and Meta-Analysis
Joint (meta-)analysis was conducted to combine the results of the
two family studies and then to combine all three studies (Table S6).
Table 5. P values from rank transformed traits and effect sizes from the quantitative cortical scores (b) of the risk allele at markers
under the dominant model in EPHA2 for each separate study and for the joint analysis of all studies.
Trait and SNP RA
a Individual Study Analysis (b)
b Meta-Analysis (Z-score)
c
BDES UKTS BMES BMES Trend Family Set All
Cortical Cataract Score
rs7548209 C 0.4516 0.0524 0.0365 (0.85) - 0.1561 0.0747
rs3754334 A 0.3935 0.0252 (2.95) 0.0734 - 0.1205 0.0180 (2.37)
Arg721Gln A2 610
28 (9.20) MS NA - - -
rs3768293 G 0.0016 (1.24) 0.0439 (2.94) 0.2705 - 3610
24 (3.65) 9610
24 (3.34)
rs6603867 C 1610
24 (1.58) 0.8325 0.2411 - 4610
25 (4.13) 0.7110
rs6678616 A 7610
25 (1.24) 0.5249 0.1520 - 1610
24 (3.90) 1610
24 (3.87)
Haplotype
rs7548209-rs3754334 CG - - 0.0024 (2.36) - - -
rs7548209-rs3754334 GG - - 0.0202 (20.74) - - -
rs6603867-rs6678616 CA - - 1610
26 (6.57) - - -
Severe Cortical Cataract
rs7548209 C 4610
26 3610
24 0.1051 0.0027 8610
29 (5.78)
d 0.3884
rs3754334 A 0.0225 1610
24 0.0196 0.0065 2610
24 (3.70)
d 0.1602
Arg721Gln A8 610
25 MS NA - - -
rs3768293 G 7610
26 0.0040 0.0433 0.0140 9610
28 (5.34)
d 0.0037 (2.91)
d
rs6603867 C 2610
25 0.0150 0.0435 0.0265 7610
25 (3.97) 0.0409 (2.04)
rs6678616 A 0.0215 0.0152 0.3788 0.0452 0.0014 (3.19)
d 0.0271 (2.21)
Cells with a dash indicate that the analysis was not performed.
aRA represents risk alleles (reference alleles).
bMS and NA represent monomorphic SNPs and SNPs that were not analyzed because of small variance under the dominant model, respectively. The Cochran-Armitage
(additive) trend test (BMES Trend) was also used to conduct a case-control association test of individuals age-matched for severe or no cortical cataract in the BMES.
Parentheses in each individual study for cortical cataract represent effect sizes (b).
cParentheses in meta-analysis represent Z-scores.
dIn the meta-analyses, these SNPs for severe cortical cataract show significant P values for heterogeneity tests of effect sizes (Q test P,0.05).
doi:10.1371/journal.pgen.1000584.t005
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cataract trait values using the two family sets and all three datasets
was found with rs6603867 (P=4610
25) and rs6678616
(P=1610
24), respectively (Table 5). There was no significant
heterogeneity for cortical cataract scores under the dominant
model (P.0.05) with these two significant SNPs (Table S6A). For
severe cortical cataract, rs7548209 (P=8610
29) and rs3768293
(P=0.0037) were the most significant markers when combining
the two family datasets and when combining all three datasets,
respectively (Table 5). We noted that the SNPs for the severe
cortical cataract trait showed heterogeneous effect sizes across
studies (Table 5). Nevertheless, the direction of the association for
the full spectrum of cortical cataract was the same among all three
studies (Tables S3, Table S4, and Table S5). Diversity in effect
sizes among the three datasets for severe cortical cataract is not
surprising, because the proportion of severe cases in each study is
different (Table 2). As a result, meta-analysis of all three datasets
did not improve the overall significance of the results (Table 5).
However, single SNP association, haplotype association, and
meta-analysis consistently identified that two independent associ-
ation signals are present in the 39 (rs7548209 and rs3754334) and
the 59 (rs3768293, rs6603867, and rs6678616) regions of the gene.
Figure 3. Characterization of a new coding variant Arg721Gln in exon 13. (A) An example electropherogram of the coding strand is displayed
for an affected and an unaffected individual, with the arrow marking the variant. Individuals with disease were heterozygotes (CAG) for Gln/Arg while
unaffected individuals were homozygotes for Arg/Arg (CGG). (B) A large family with cortical cataract was examined and the co-segregation of
Arg721Gln with cortical cataract determined. Two members (3-1 and 3-2) and one marry-in (3-3) were GG (Arg/Arg) but have cortical cataract,
suggesting phenocopies. Symbols filled with black or gray represent those affected with severe ($25% of the lens affected) or moderate
(5%#score,25%) cortical cataract, respectively. In the parent generation, all heterozygotes for the Arg721Gln variant developed severe cortical
cataract or have had cataract surgery. However, this variant has age dependent penetrance, as individuals who developed severe disease are older
(e.g. individual 3-4 who is 80 years old). Individuals in the offspring generation who are at risk may not have developed full-fledged cortical cataract
(e.g. 4-1 who is less than age 65 with moderate cataract, or 4-2 who is a carrier but remains free of disease at age 63).
doi:10.1371/journal.pgen.1000584.g003
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the 59 regions is less than 0.4 (Table 5), arguing for more than one
susceptibility variant being present in these samples.
Discussion
We report here that EPHA2 is essential in maintaining the
clarity of crystalline lens in aging mice and is associated with age-
related cortical cataract in humans. EPHA2 protein is expressed in
the cortical lens fiber cells, and homozygous deletion of Epha2 in
mice caused progressive cortical cataract. At the molecular level,
cataractogenesis was preceded by accumulation of underpho-
sphorylated HSP25, indicating elevated stresses and protein
misfolding in Epha2
2/2 lens. In human studies involving three
independent Caucasian populations, we discovered common
polymorphisms, as well as a rare variant that significantly altered
the function of EPHA2 kinase activities and cellular functions.
Therefore, converging evidence from genetically engineered mice
and human population studies, coupled with in vitro cell-based
assays, strongly suggest that EPHA2 is the first major genes
associated with the common form of cataract. The involvement of
a receptor tyrosine kinase in cortical cataract etiology points to
future directions in designing new preventive and therapeutic
approaches for cortical cataract by targeting EPHA2.
Prior to this study, the only noticeable phenotype reported in
Epha2 knockout mice is the kinked tails, which develops during
early embryogenesis [20]. For yet unknown reasons, the
penetrance of this phenotype has been quite low in the large
Figure 4. Concordant conservation of Arg721 and Asp872 in EPH kinase domains. (A) Examination of crystal structure of EPHA2 kinase
domain reveals that Arg721 in aE forms a salt bridge with Asp872 in aI. (B) Concordant conservation of Arg721 and Asp872 in different members of
human Eph kinases. Note that EPHA9 and EPHB5 are not present in human genome and are not shown. (C) The same residues are also concordantly
conserved across different species.
doi:10.1371/journal.pgen.1000584.g004
EPHA2 in Age-Related Cortical Cataract
PLoS Genetics | www.plosgenetics.org 10 July 2009 | Volume 5 | Issue 7 | e1000584cohorts of the same strain of knockout mice maintained in our
facility on either FVB/NJ or C57Bl/6 genetic background. In
another stain of Epha2 knockout mice generated by the secretory
trapping strategy [17,18], the incidence of kinked tails was also
very low. This is in contrast with cataract phenotype reported here
that is observed in significant fraction of both strains of
homozygous knockout mice.
There are several unique approaches in our study compared
with other studies to identify genes involved in complex disease.
First, we utilized two independent lines of Epha2 knockout mice
that were extensively investigated for potential molecular implica-
tions in cataractogenesis. This effort provided confidence in
subsequent studies pursuing causal variants in human populations.
Second, we investigated association with polymorphisms of
EPHA2 in worldwide Caucasian populations from the United
States, United Kingdom, and Australia. Phenotypic measurements
were comparable among the three datasets, but there was
variability in the extent of severity of cataracts in these
populations. The most severe forms of cataract were associated
with rare variants that were unique to each population and there
was little replication between populations. Common variants could
be replicated across populations with a greater degree of certainty.
To ensure validity of the results, we extensively examined
diagnostics of the final models in the family data. A candidate
gene study using family data, unlike a genome-wide association
study using unrelated data, requires special techniques to ensure
the validity, i.e. normality of the model residuals expected
asymptotically and required for the P values that presume
normality to be valid. We applied the George-Elston transforma-
tion to both sides of the regression equation in the association tests
[27]. We confirmed the normality of the residuals in the final
models for all SNPs (Figure S4).
Our studies led to the successful identification of a non-
synonymous variant, Arg721Gln, residing in the protein kinase
domain of EPHA2. Moreover, the variant showed increased
spontaneous activation in the absence of ligand stimulation,
suggesting that the coding variant alters the spontaneous and
ligand-triggered cellular signaling. The altered signaling is
Figure 5. Functional characterization of Arg721Gln variant associated with human cataract. (A,B) Arg721Gln mutation causes an increased
basal activation of EPHA2 kinase, which was correlated with dramatically reduced basal ERK1/2 activities. In a kinetic study (A), HEK 293 cells
expressing WT-, Arg721Gln-EPHA2 or vector control were stimulated with 2 mg/ml ephrin-A1-Fc for the indicated times. In a separate experiment, a
dose-response study was carried out (B), where different doses of ephrin-A1-Fc were used to stimulate cells expressing WT- or Arg721Gln-EPHA2 for
10 min. Cell lysates from both experiments were blotted with the indicated antibodies as described previously [53]. (C) HEK 293 cells expressing
Arg721-Gln mutant EPHA2 but not WT-EPHA2 were growth-inhibited by ephrin-A1 in a clonal growth assay as described previously [26]. About 200
cells/well were seeded in a 24-well culture dish and cultured for 10 days in the presence or absence of ephrin-A1. (D) Stochastic intracellular trapping
of Arg721Gln mutant in MEF cells derived from Epha2 knockout embryos. Shown is a cluster of cells with the mutant EPHA2 trapped inside the cells.
In contract, WT-EPHA2 was primarily expressed on the cytoplasmic membrane. Scale bar: 5 mm.
doi:10.1371/journal.pgen.1000584.g005
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human (A), or phylogenetic shadowing in human-primates (B), or a tag-based approach using LD from the CEU HapMap sample (C). Markers in blue
are in phylogenetically conserved areas, in black are tag-based, and in pink are identified via re-sequencing (D). Single marker results are reported
using the full range of quantitative cortical cataract scores (CCQT) and the extreme phenotypic contrast for cortical cataract (severe CC), from the
BDES, BMES, and UKTS. Meta-analysis results are shown using the two family studies (BDES and UKTS) and using all three studies (BDES, BMES, and
UKTS). We plotted 2log10(P value) from the likelihood ratio test for CCQT and severe CC at each marker (D). The dashed line represents the 0.05 P
value after adjusting for multiple testing for the genotyped SNPs and multiple models (0.05/[19 markers63 genetic models62 traits]=4610
24). (E)
Window sizes of 2–5 markers were used to identify the most significant haplotypes in the 39 (HT1) and the 59 (HT2) region using percent of the lens
affected by cortical cataract in the BMES, the sample of unrelated persons.
doi:10.1371/journal.pgen.1000584.g006
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stochastic intracellular retention in primary fibroblasts. The
reason for the cytoplasmic retention in only some, but not all
cells expressing the mutant is not clear at present. Regardless of
the mechanisms, cytoplasmic trapping is likely to interrupt both
signaling and structural functions of EPHA2/ephrinA system in
the lens fiber cells. Because EphA2 is essential for maintaining lens
clarity as evidenced by cataractogenesis in homozygous knockout
mice, functional alterations in EphA2 is likely to impair its
physiological roles in the lens, predisposing the carriers to
increased risk of cataract development.
In addition to this rare variant, common polymorphisms were
also discovered and replicated in worldwide Caucasian populations,
suggesting that EPHA2 could be involved in predisposition to
cataractogenesis in the general population. The most significant
common variant for the quantitative cortical cataract trait was
rs6678616 in the region coding for the ligand binding domain of the
EPHA2 gene. Bioinformatic investigation revealed that rs6678616 is
located in an exonic splicing enhancer element, and nucleotide
changes of the SNP may potentially affect the affinity of splicing
enhancer factors up to 14-fold (data not shown). The most
significant SNP, rs7548209, for severe cortical cataract is present
in a downstream conserved non-coding region of the EPHA2 gene.
Characteristics of this variant are not known. It is possible that such
a variant may affect EPHA2 expression during aging.
While this manuscript was under preparation, it was reported
that mice with homozygous deletion of Efna5 encoding a ligand
(ephrinA5) for EPHA2 also developed cataract [28]. These data
nicely complement the data described in this paper, and
demonstrate that both the receptor (EPHA2) and the ligand
(ephrinA5) are required for maintaining lens clarity. In addition,
recent genetic studies involving a relatively small number of affected
individuals have found a link between congenital cataract and
variants of EPHA2, although none of rare variants were functionally
characterized [29]. These recent results on rare congenital cataract
support our conclusion on the link between EPHA2 and the much
more common age-related cataract, based on large human
population studies and genetically engineered mice.
Since aging was the most important risk factor for age-related
cataract, age-dependent reduction of EPHA2 protein expression in
normal lens and age-dependent deterioration of lens clarity in
Epha2 knockout mice suggests an important role of EPHA2 kinase
in cataractogenesis during aging. Previous studies have shown that
EPHA2 regulates epithelial cell morphogenesis and homeostasis in
part by interacting with components of adherens and tight
junctions, such as claudins and cadherins [30]. Notably, the lens
is primarily composed of lens fiber cells where intricate cell-cell
interactions are essential for structural and functional integrity.
Changes of EPHA2 expression or function due to aging or genetic
predisposition can impair junctional structure, leading to excessive
cellular stress and eventual opacity.
Recent studies show that there are common genes and pathways
among late onset neurodegenerative diseases, including Alzhei-
mer’s disease, multiple sclerosis, diabetes, and age-related eye
disease. Genes involved in neurodegenerative diseases, kinesin
light chain 1 [11] and apolipoprotein E [12], showed association
with age-related cataract. Also, there is evidence of a link between
longevity and age-related cataract [31]. Successful aging, defined
as preserved cognition, is associated with reduced age-related
cataract among the elderly [31]. Microarray expression analysis
proved that lens expresses brain specific molecules, including b-
amyloid secretases and degrading enzyme [32], synapsin and
synaptic vesicle protein [33], and brain-specific miRNAs [34].
This suggests that common genes and pathways may be involved
in both age-related cataract and neurodegenerative diseases
affecting the elderly population. Since the EPH/ephrin system is
known to be critical for neural development [35] and vision
processes in the midbrain [36], the EPH and EFN genes may be
potentially involved in a broad spectrum of age-related eye and
neurodegenerative diseases. Further functional investigation of
these genes will elucidate pathogenic mechanisms leading to age-
related cataract and other late onset diseases.
In summary, converging evidence from mouse and humans
demonstrates that EPHA2 has an important role in maintaining
lens transparency. While genetic predisposition is known to be a
major contributing factor to age-related cortical cataract, our
study has identified and characterized genetic variants of the
EPHA2 gene in human, and both common and rare variants
confer risks for cortical cataract.
Materials and Methods
Animals
The KST085 line of Epha2 knockout mice was generated
through secretory gene trapping as described previously [18]. The
secretory trapping vector was inserted at the boundary between
exon 5 and intron 6, leading to the truncation of exons 6 to 17
encoding the second fibronectin type III repeat in the extracellular
domain all the way to the carboxyl terminal end. The remaining
ectodomain encoded by exons 1 to 5 is fused to neomycin
resistance and b-galactosidase reporter cassette (b-geo) and is
trapped inside the cells in secretory vesicles, presumably in inactive
form. These mice, which were generated on a C57Bl/6/129
genetic background, were then backcrossed with FVB/N mice.
Mice from N4 or higher backcrosses were bred with each other to
generate Epha2
+/+, Epha2
+/2, and Epha2
2/2 mice that were used
in subsequent studies. Another line of mice on C57Bl/6
background was provided by Drs. M. Asano and Y. Iwakura
[20]. In these mice, a retrovirus was inserted in the first codon of
Epha2, leading to abolishment of EPHA2 expression.
All procedures involving mice were performed in accordance
with guidelines set forth by the American Association for
Accreditation of Laboratory Animal Care and the USPHS ‘‘Policy
on Humane Care and Use of Laboratory Animals.’’ Studies were
approved and supervised by The Case Western Reserve University
Institutional Animal Care and Use Committee.
Histological Analysis and Immunofluoresence
For histological analyses, mouse eyes were enucleated and fixed
in neutral buffered 10% formalin solution for 24 hours. Eyes were
dehydrated through a graded alcohol series and embedded in
paraffin. Sections (5 mm) were cut through papillary-optic nerve
axis and stained with hematoxylin and eosin (H&E).
For immunofluorescence analyses, postnatal day 14 eyes were
dissected, fixed with 4% paraformaldehyde for 25 min. Eyes were
washed with ice cold Phosphate Buffered Saline (PBS) and kept in
15% sucrose (prepared in PBS) overnight. Tissue freezing medium
(Triangle Biomedical Science, Durham, NC) embedded eyes were
cut on a cryostat (Leica, Germany), and air dried onto Superfrost
Plus slides (Fisher Scientific). After washing with PBS, the sections
were blocked with 50 mmol/L NH4Cl and permeabilized with
0.3% NP40 for 10 minutes. The sections were then incubated with
primary antibodies at room temperature for 1 hour followed by
detection with donkey secondary antibodies conjugated with FITC
or Texas-red (Jackson ImmunoResearch, West Grove, PA) at
room temperature for 30 minutes.
EPHA2 and Ephrin-A1 proteins were detected in human and
mouse lens paraffin-embedded sections. Briefly, sections were
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sodium citrate, 0.05% Tween 20, pH 6.0) for 10 minutes at 95uC.
Primary antibodies were incubated with samples and then
detected by Biotinylated secondary antibody and avidin–biotin–
peroxidase system (Vector). Color immunostaining was revealed
using diaminobenzidine (Vector). Images were taken using a
fluorescent Leica DM-IRE2 microscope equipped with a SPOT
RT-SE digital camera (Diagnostic Instrument) and analyzed with
MetaMorph software 6.1r4 (Universal Imaging).
Antibodies used include: goat anti-mouse EPHA2 ectodomain,
goat anti-human EPHA2 (R&D Systems, Minneapolis, MN),
rabbit anti-EPHA2 and anti-ephrin-A1, goat anti-HSP25 and
mouse anti-phospho-ERK, rabbit anti-ERK (Santa Cruz Biotech-
nology, Santa Cruz, CA), rabbit anti-phospho-HSP25, anti-
phospho-AKT, anti-Akt, anti-GAPDH (Cell Signaling), mouse
monoclonal anti-N-cadherin (BD Biosciences). Rabbit-anti-a,b,c-
crystallin were kindly provided by Dr. Zigler (National Eye
Institute).
Tissue Extraction and Immunoblot Analysis
Lenses were dissected from eyes and homogenized in ice-cold
lysis buffer containing 20 mmol/L Tris (pH 7.4), 125 mmol/L
NaCl, 10% glycerol, 1% Triton X-100,0.5% DCA, 0.1% SDS,
20 mmol/L NaF, 1 mmol/L phenylmethylsulfonyl fluoride, mg/
mL aprotinin, 4 mg/mL leupeptin, and 1 mmol/L Na3VO4. Then
samples were centrifuged at 13,000 g for 10 minutes at 4uC.
Protein concentrations in supernatant were assessed using the
bicinchoninic acid protein assay kit (Bio-Rad, Hercules, CA).
Equal amounts of protein extracts were resolved by 4–20% SDS-
PAGE and electrotransferred onto polyvinylidene difluoride
membranes (Millipore, Bedford, MA), which were then blotted
with the indicated antibodies.
Slit Lamp Biomicroscopy
Mice were anesthetized by an intramuscular injection of
Tribromoethanol at 200 mg/kg body weight followed by induc-
tion of mydriasis with tropicamide (1%) and phenylephrine (10%).
The lenses were examined with slit lamp and the observations
were recorded by digital photography.
Subjects
The Beaver Dam Eye Study. The Beaver Dam Eye Study
(BDES) is a population-based cohort study for age-related ocular
diseases and was used as a discovery sample set. Informed consent
was obtained from the participants following a protocol approved
by the Institutional Review Board (IRB) of the University of
Wisconsin; the tenets of the Declaration of Helsinki were observed.
The population, the methodology, and the baseline parameters are
described in detail elsewhere [37]. Genome-wide linkage was
previously examined in this cohort using microsatellite markers
and we obtained evidence for a cortical cataract locus on 1p36
[13]. DNA and phenotypes were available for 1401 individuals in
494 families. Characteristics of genotyped individuals were not
different from those in the rest of the cohort; therefore, the
genotyped data can be extrapolated to the full cohort.
Retroillumination photographs were used to quantify cortical
cataract. The lens photographs were graded based on the
Wisconsin Cataract Grading System [37]. For grading cortical
cataract, a grid was used with a central circle that occupies 2% of
the entire lens surface, and subfields covered the remaining area,
where each subfield was 12.25% of the total area. The percentage
of each subfield with opacity was recorded and combined into a
percentage of total opacity involvement for the eye. We used worst
scores of cortical cataract during the 15-year observation period as
quantitative traits. We also defined a binary trait of severe cortical
cataract status: if the score indicated that $25% of the entire lens
in either eye was affected we classified them as affected, whereas
unaffected individuals were those with cortical scores,1% for the
worse eye. The history of affection status during the 20 -year
observation period from baseline (prevalent) and three follow-up
(incident) phases of the study was reviewed to classify individuals
into a binary classification, affected/unaffected, of cortical
cataract, eliminating those with intermediate scores.
We adjusted for covariates that were previously identified by
epidemiologic studies [38–42]. Risk factors included continuous
variables such as age at baseline (years; age) and highest body mass
index(bmi;height divided bysquareofweight),and ordinalvariables
such as gender (male=1, female=0), diabetes status (dm; never
affected at any time point=0, moderately affected=1, and severely
affected=2), history of heavy alcohol intake (four or more alcoholic
drinks per day; never=0, past=1, and current=2), history of
cigarette smoking, defined as more than 100 cigarettes smoked
during the lifetime (smoke; never=0, past smoker=1, current
smoker=2) , and age-related macular degeneration affection score
(amd; 15-step score) [43]. Each covariate was considered indepen-
dentlyand with second order(polynomial)terms,intheanalysis.We
also evaluated interaction terms between covariates. Each pheno-
type was predicted by a different set of risk factors. We selected the
final models for the quantitative and binary traits using stepwise
linear and logistic regression models, respectively. The quantitative
cortical cataract was predicted by age and gender, and the binary
cortical cataract was predicted by age and age
2. We used residuals
from each final model as the initial trait in our association analysis.
The United Kingdom Twin Eye Study. The United
Kingdom Twin Eye Study (UKTS) consists of a total of 506
white female twin pairs (226 monozygotic and 280 dizygotic),
between ages of 49 and 79 from the UK Adult Twin Registry [5].
IRB approval was obtained from the St Thomas’ Hospital Local
Research Ethics Committee, and all subjects signed informed
consents. The research followed the tenets of the Declaration of
Helsinki. Similar to the BDES, the UKTS sample showed
evidence for linkage on chromosome 1p36 (D1S2697; P=0.001).
A total of 219 participants were available with DNA and cataract
phenotypes. Both individuals from 13 dizygotic twin pairs were
included in analyses. As 23 pairs were monozygotic twins, the twin
with the more severe cataract score or with DNA available was
retained for analysis. Thus, the number of individuals in the final
analysis was 185 individuals from 172 families.
In UKTS, cortical cataract scores were graded from 0 to 5 in
decimalized steps, which could be converted to percent of the lens
affected on multiplying by a factor of 20. In the digital grading
procedure, photos taken from participants were stored using a
digitized retroillumination camera system and analyzed using the
Wilmer Automated Cortical Cataract Grading System [5]. Similar
to the BDES sample, a binary variable for severe cortical cataract
was defined: a cortical score greater than or equal to 25% as
‘affected’ and no sign of cortical cataract (score=0) as ‘unaffected’.
To adjust for risk factors in the UKTS, the following covariates
were tested: age (years), average alcohol intake from current and
previous periods (units per week; alcohol), history of smoking (in the
past or current; smoke), and average systolic blood pressure from
initial and subsequent measurements (measured in mm Hg; sysbp).
Diabetic status was not considered because of the large amount of
missing data (percent missing=52.3%). When testing significant
covariates, we considered polynomial functions (e.g. age
2) as well
as first-order interactions between any two covariates. We selected
the final models for the quantitative and binary traits using
stepwise linear and logistic regression models, respectively. The
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smoke, sysbp
2, interaction between age and bmi, interaction between smoke and
bmi, interaction between smoke and alcohol, and interaction between sysbp and
alcohol. The binary severe cortical trait was predicted only by age,
age
2, smoke, sysbp
2, alcohol
2, interaction between age and bmi, interaction
between age and alcohol, interaction between alcohol and bmi, and interaction
between smoke and alcohol. The residuals for the severe binary and
quantitative cortical cataract traits were used in the association
analyses.
Blue Mountains Eye Study. The Blue Mountains Eye Study
(BMES) collected data in a suburban Australian population aged 49
years and older at baseline [44]. Ethics approval was obtained from
the University of Sydney and Sydney West Area Human Research
Ethics Committees, and written informed consent forms were
collected from all study subjects; the research followed the tenets of
the Declaration of Helsinki. BMES is unascertained for disease with
the sampling frame based on postal codes in the region of the Blue
Mountains area, west of Sydney. It has never been tested for
association of age-related cataract with any locus [44].
All the definitions for cataract traits determined in the BMES
followed the same grading protocol as that used in the BDES.
Related individuals were excluded (N=99) by only keeping the
oldest individual from each family. The oldest individuals were
selected because they were likely to bear the most amount of
phenotypic information. A total of 1470 individuals were available
with DNA and phenotypic data after removing related individuals.
We considered as risk factors continuous variables such as age
(years; age) and systolic blood pressure (measured in mm Hg; sysbp),
and the ordinal variables gender (male=1, female=0), hyperten-
sion status (hypt; severely affected at any time point=2, moderately
affected=1, and never affected=0), history of heavy smoking,
defined as more than 100 cigarettes smoked during the lifetime
(smoke; never=0, past=1, and current=2), and age-related
macular degeneration affection score (amd; 15-step score). We
selected the final models for the quantitative and binary traits
using stepwise linear and logistic regression models, respectively.
The quantitative cortical cataract score was predicted by gender and
age. The binary severe cortical cataract trait was predicted by
smoke, sysbp, interaction between age and gender, interaction between age and
sysbp, and interaction between sysbp and smoke. We used residuals from
each final model as the trait in our association analysis, for both
the severe binary and quantitative cortical cataract trait.
Re-sequencing
We selected 34 individuals for re-sequencing, 19 of whom had
severe cortical cataract (worst cortical score $25% of lens
involved), 15 were unaffected family members with no evidence
of cataract formation (worst cortical score ,1%) at $70 years of
age, representing 18 families. Our rationale for choosing this set of
individuals for re-sequencing was that they were previously shown
to be linked to markers at 1p36 [13] and we hoped to find coding
variants associated with disease, in addition to finding neutral
variants.
To identify linked families, sib pairs from the SIBPAL program
(version 5.3.1) in the candidate region (1p36) were ranked for
linkage informativity [45]. For each sibling pair, a score based on
the squared sib-pair difference and the estimated sib-pair marker
allele sharing was computed:
y{ y1{y2 ðÞ
2
hi
^ p p12{0:5 ðÞ ,
where y1 and y2 are the trait values for sibs 1 and 2, y is the
average of y1{y2 ðÞ
2 over the whole sample, ^ p p12 is the estimated
mean allele sharing for the two sibs. This score is large (positive)
either when the squared sib pair difference of the trait value is
small and ^ p p12 is large or when the squared sib-pair difference is
large and ^ p p12 is small, which means the sibs are similarly alike, in
terms of deviation from the mean, for both their traits and allele-
sharing; otherwise the score will tend to be small (negative).
Therefore, all the sibpairs with positive values were considered to
be contributing to linkage.
All 17 EPHA2 exons along with 50–100 base pairs of the
surrounding intronic junctions were sequenced with the polymer-
ase chain reaction (PCR) with primers designed using the
PrimerSelect program (version 4.05) in the DNASTAR software
(Table S1). For each amplicon, the PCR conditions for
amplification are described in Table S1. After PCR, the product
was purified using ExoSAP-IT enzyme (16;2ml of the ExoSAP-
IT enzyme with 10 ml PCR product for a final concentration of
5 ng/ml) and the product sizes were confirmed on a 1.5% agarose
gel. The amplified PCR products along with primers were sent to
McLab (San Francisco, CA) for sequencing. Electropherograms
were examined using the ChromasPro program (version 1.4) and
new variants not previously reported in the literature were
confirmed by sequencing in the reverse direction.
Single Nucleotide Polymorphism (SNP) Selection
We selected SNPs for full-scale genotyping via three strategies:
re-sequencing, tag-based selection using the linkage disequilibrium
(r
2), and phylogenetic mining. Based on the results of re-
sequencing, three rare coding variants and a common SNP were
selected for follow up in the remaining individuals of the discovery
data. For the tag-based approach, linkage disequilibrium (LD) in
EPHA2 was investigated by examining SNPs from 10 Kb
upstream (+10 Kb) to 10 Kb downstream (210 Kb) of the gene
(16,323,419–16,355,151 bp) in HapMap data (CEU; Centre
d’Etudes du Polymorphisme Humain; Utah residents with
ancestry from northern and western Europe, HapMap Data,
Data Rel 21 a/phaseII Jan07, on NCBI B36.3 assembly, dbSNP
b130) using the HAPLOVIEW program (version 3.1). We selected
at least one SNP in each block based on HapMap data to get four
tagging SNPs.
Phylogenetic footprinting [46] and phylogenetic shadowing [47]
were used for additional SNP selection. Under the assumption that
non-coding regulatory regions are conserved through evolution,
direct genotyping of non-coding conserved SNPs may increase
power in chromosomal regions with low LD. We examined
mouse-human sequences to maximize the number of inter-species
conserved regions. The EPHA2 sequences from human (Homo
sapiens) and mouse (Mus musculus) were aligned using zPicture. We
used window size width of $100 bp with $70% identity between
human and mouse [48]. In the phylogenetic shadowing approach,
using multiple sequence comparisons among primates, sequence
elements (blocks) that did not change among primates are
identified as regulatory elements [47]. We identified the non-
coding conserved regions in EPHA2 by comparing the human
EPHA2 gene as a reference with the orthologous sequences in two
primates, the chimpanzee (Pan troglodytes) and the rhesus monkey
(Macaca mulatta) using eShadow [47]. Within each conserved block
one SNP with the highest minor allele frequency (MAF) was
selected for genotyping.
Based on the hybrid selection strategy for SNPs, we first selected
four non-redundant tag based SNPs that had MAF.5%. These
SNPs were supplemented with 11 conserved non-coding SNPs
identified through phylogenetic approaches. Finally, a set of
intriguing coding and regulatory SNPs (N=4) identified through
EPHA2 in Age-Related Cortical Cataract
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genotyped in all three datasets, the BDES, UKTS, and BMES.
SNP Genotyping and Quality Control Metrics
We used two different techniques, TaqMan and SNPlex assays,
to interrogate SNPs. The genotyping procedure was performed
according to the manufacturer’s protocol. Clustering algorithms
for genotype assignment used three quality control steps: (1)
removing wells (individuals) with a significant number of outlier
SNPs, (2) setting a SNP pass value by assigning a pass or fail status
for each SNP, and (3) for each passing SNP, a confidence value
was calculated (call rate). A confidence value of at least 95% was
required to retain a genotype call. We further cleaned the data by
removing individuals with low quality DNA across the SNPs (at
least 90% of SNPs met the threshold quality value). We calculated
the error rate and no-call rate using 5% replicate plating of DNA
prior to these filtering steps. The average error rate and no-call
rate for SNPlex genotyping was 0.7% and 3.9%, respectively. The
average error rate and no-call rate for TaqMan genotyping was
0.3% and 3.7%, respectively. Cleaned data were used in
association analyses.
All genotyped SNPs met Hardy-Weinberg equilibrium with a
nominal P.0.05. We estimated allele frequencies using the FREQ
program in S.A.G.E. (version 5.4.2), and 95% confidence intervals
were reported (Table S2). The program estimates allele frequen-
cies using a maximum likelihood formulation that assumes a
random mating population. Standard errors are computed by
numerical double differentiation of the log likelihood (Table S2).
We also examined linkage disequilibrium (LD) blocks in each
dataset using the HAPLOVIEW program (version 3.32).
Statistical Methods
Association analysis for family data. All genotyped SNPs
were tested for association using the ASSOC program in S.A.G.E.
(version 5.3.1). The method in ASSOC is a maximum likelihood
regression-based approach that allows appropriate handling of
familial correlations, estimating as necessary variance components
for polygenic, marital, family, and sibling effects as well as for individual
random effects, and that transforms both sides of the regression
equation [49] (simultaneously estimating two transformation
parameters) to remove skewness and kurtosis [27]. The model
for the i
th pedigree member is h(yi)=h(fi)+ei, where yi is the trait
value, fi=a+bgi, gi is the genetic marker value, ei is the sum of the
random effects, and h is the George-Elston generalized modulus
power transformation [27]. The George-Elston transformation is
defined as
hy ðÞ ~
sign y{l2 ðÞ
y{l2 jj z1 ðÞ
l1{1
l1
hi
, l1=0,
sign y{l2 ðÞ log y{l2 jj z1 ðÞ , l1~0:
(
This transformation involves both power (l1) and shift (l2)
parameters that are simultaneously estimated, together with the
other parameters of the model, by maximum likelihood under the
assumption of multivariate normality across family members.
Because the transformation is applied to both the trait value (y)
and its expectation f, for quantitative traits the regression
coefficients (b) are median unbiased estimates [49] to the extent
that the model fits. In the case of binary traits, because the
quantitative residuals (y) were obtained from logistic regression,
the estimated regression coefficients (b) are not meaningful with
respect to the magnitude of the effect, though they are so with
respect to their statistical significance. Three genetic models (g),
additive, dominant, and recessive with respect to a reference allele,
were assessed at each SNP. The minor allele was selected as the
reference allele. For example, a SNP in an additive model was
coded as 0, 1, or 2 according to the number of reference alleles,
whereas it was coded as 0 or 1 in a dominant model according to
the absence or presence of the reference allele.
To find the best model for the familial correlation structure,
each familial variance component was tested in the model by itself
and in combination with others. The most significant, but
parsimonious, model was retained as the ‘‘null’’ model against
which was contrasted models containing the SNPs as covariates.
For the two family datasets BDES and UKTS, the variance
components for sibling and random effects, along with a genetic model
for a SNP, were included in the final analysis. For each SNP, the
baseline model without the SNP covariate and an alternate model
with the SNP covariate were contrasted. The likelihood was
maximized with respect to the null model containing the variance
components and the baseline parameter a, and the alternate
model containing the same variance components and both a and
b. We performed likelihood ratio tests by comparing twice the
difference between two log likelihoods with a chi-square
distribution, and Wald tests by dividing each estimate of b by its
standard error, estimated by numerical double differentiation of
the log likelihood, and comparing the quotient to a standard
normal distribution. Thus we obtained two P values that would be
asymptotically identical.
We examined the residuals ([h(yi)2h(a+bgi)]) in a final model
that included the most significant SNP by plotting a normal
quantile-quantile (normal Q-Q) plot. Regardless of the distribution
of y, normality of the residuals is required for the association result
to be valid. We also conducted association analyses on the
normalized traits, forcing the marginal distribution of the analyzed
trait to be about normally distributed under the null hypothesis, by
taking the inverse standard normal transformation of the empirical
quantile that was obtained from the formula [r(y)21/3] divided by
(n+1/3), where r(y) is the rank of y [50]. To evaluate the ability of
the George-Elston transformation to achieve normality, we
compared residuals without transformation to those with the
George-Elston transformation, and to those with the George-
Elston transformation when the initial trait was inverse normal
transformed. We examined the distributions of residuals from the
final models using the quantitative cortical cataract trait in the
BDES and in UKTS. Since the estimates (b-coefficients) for the
quantitative trait, after the George-Elston transformation is
applied to both sides of the regression equation, are median
unbiased estimates, we report these estimates as our effects that
measure net change, after adjusting for other covariates, due to a
dominant or recessive genotype, or per copy of a reference allele
(additive model). The estimate measures the net percentage
change in cataract score ranging from 0 to 100%.
For the severe binary cortical cataract trait, as the George-
Elston transformation was not sufficient to obtain normality in
both family datasets, we report only P values from inverse normal
transformed traits. For comparability, P values from both the
quantitative and binary traits in the main text were from inverse
normal transformed traits, and estimates for the quantitative
cortical cataract were only reported for quantitative traits without
inverse normal transformation. We also report P values from the
likelihood ratio tests and Wald tests of the inverse normal
transformed quantitative and binary traits.
Association analysis for unrelated data. For the unrelated
BMES data, we performed ordinary least squares regression of
quantitative traits on allele dosage as implemented in the PLINK
program (version 1.0.1) [51]. We used Wald tests based on t-
distributions, and regression coefficients (b-coefficients) and
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Armitage (additive) trend test using an age-matched (age at least
70 years) case-control set, comprising cases with cortical score
$25% and controls with cortical score ,1%. The PLINK
program performs a chi-square test for association on the fourfold
allele table, and reports asymptotic P values and the estimated
odds ratios for the minor allele. We also report the 95%
confidence intervals for the odds ratios.
After single SNP association tests, for which the P values were
moderate, we conducted haplotype-based association tests in the
unrelated data in order to explore the improvement in
significance. Using the five most significantly associated SNPs
(rs7548209, rs3754334, rs3768293, rs6603867 and rs6678616),
moving windows of different sizes (sizes 2 to 5) were applied using
the PLINK program (version 1.0.1). The PLINK program
probabilistically infers haplotypes for each individual based on
the standard expectation-maximization phasing [51]. We tested
the association of haplotypes with the quantitative cortical cataract
trait and obtained regression coefficients (b), t-statistics, and
asymptotic significance values for the coefficients.
Heterogeneity test and meta-analysis. We tested
heterogeneity of effect sizes for SNP associations using the Q
test assuming a random-effects model, which estimates the
variability of the population effect size across studies [52]. In this
model, we assume population effect sizes (bi) are heterogeneous
among studies and follow a normal distribution with mean mb and
variance s2
bzs2
ei. This assumes the individual sampling errors are
independent and normally distributed with variance s2
ei. This
assumption is valid, especially when residuals from the final model
are normally distributed. The Q statistic was constructed using the
formula, Q~
P k
i~1
wi bi{b
   2
, where wi~ 1
s2
bzs2
ei
, b~
P k
i~1
wibi
P k
i~1
wi
, and k
is the number of studies. Under the null hypothesis (s2
b~0)
andwi~ 1
s2
ei
, the Q statistic asymptotically follows a chi-squared
distribution with k-1 degree of freedom. The null hypothesis will
be rejected at the 5% level when the observed test statistic exceeds
the 95
th percentile of a chi-squared distribution. We used effect
sizes (bi) and sampling variances (s2
ei, squared standard errors of
the estimates) to calculate the Q statistic. Asymptotically, when the
sample sizes of all k studies are sufficiently large, the Q statistic
follows a chi-squared distribution.
We conducted meta-analysis using the METAL program, which
calculates an overall z-statistic and P value from the weighted
average of the individual statistics, accounting for sample size by
calculating the square-root of the number of individuals examined
in each sample (http://csg.sph.umich.edu/). We report N, total
number of analyzable valid individuals, Z-scores, and overall P
values in the combined dataset.
Supporting Information
Figure S1 Morphological, histochemical and biochemical char-
acterization of wild type and mutant mouse lens. (A) H&E sections
of lenses from eight-month- and two-week-old mice. Note
abnormal structure of the Epha2 homozygous knockout lens. Scale
bars: 1 mm for left two panels; 10 mm for right two panels. (B)
Anterior view of an intact Epha22/2 lens stained with X-gal to
detect LacZ reporter gene expression. With 3-hour short-term
staining, expression in epithelial cells on lens surface but not in
deeper fiber cells was detected. (C) X-gal staining of frozen sagittal
section showing LacZ reporter expression pattern. Inset is shown
in (D). Scale bars: 1 mm for B and C; 10 mm for D. (E) Staining of
an Epha22/2 lens using an antibody recognizing the ectodomain
of EPHA2. Because part of the EPHA2 ectodomain was fused to
LacZ reporter gene, the staining pattern is similar to that of X-gal
as in D; both were trapped in the secretory vesicles. F) EPHA2
protein expression in the isolated lens cortex and nuclei. Note the
age-dependent decrease in EPHA2 expression. Same amounts of
protein extracts were loaded as indicated by Ponceau S staining.
Found at: doi:10.1371/journal.pgen.1000584.s001 (2.87 MB TIF)
Figure S2 EPHA2 expression in human lens. (A) Lysates were
prepared from two 56 and 60 year old human lenses and blotted
for EPHA2. (B–D) EPHA2 staining of human lens: Images from
sagittal sections at anterior (B) and posterior (C) regions and
coronal section near the equator (D) are shown. (E) Negative
control without primary antibody. Scale bars: 5 mm.
Found at: doi:10.1371/journal.pgen.1000584.s002 (4.16 MB TIF)
Figure S3 Crystallin expression and activation status of Akt and
ERK1/2 kinases in wild type and mutant mice. (A) Epha2 deletion
did not cause significant changes in crystallin expression until
development of mature cataract. Each lens from the indicated age
was extracted with RIPA buffer first. After centrifugation, the
supernatant was collected as soluble fraction. The pellet was
directly dissolved in protein gel loading solution containing 2%
SDS. The soluble and insoluble fractions were separated and
blotted with the indicated antibodies. (B) Epha2 deletion did not
significantly alter the ERK1/2 and Akt kinase activities. Total lens
proteins were extracted with RIPA buffer and subject to
immunoblot with the indicated antibodies.
Found at: doi:10.1371/journal.pgen.1000584.s003 (1.29 MB TIF)
Figure S4 Normal Quantile-Quantile (Q-Q) plots from residuals
under the dominant model. The first column is the residuals from
the initial trait without any transformations (NOTF), the second
column is the residuals from the initial trait with the George-Elston
transformation (GETF), and the third column is the inverse
normal transformed adjusted data with the George-Elston
transformation (INV-GETF). (A–B) Normal Q-Q plots from
residuals of the Arg721Gln variant were plotted for the BDES.
(A) The plots were drawn for cortical cataract. (B) The plots were
drawn for severe cortical cataract. (C–D) Normal Q-Q plots from
residuals of rs7548209 were plotted for the UKTS. (C) The plots
were drawn for cortical cataract. (D) The plots were drawn for
severe cortical cataract.
Found at: doi:10.1371/journal.pgen.1000584.s004 (0.76 MB TIF)
Figure S5 Retroillumination images of normal human lens vs.
lens with cortical cataract. A normal human lens. (A) compared
with cortical cataract lens from the Beaver Dams Eye Studies
(BDES) (B) and Blue Mountain Eye Studies (BMES) (C). (D) A
panel of retroillumination images from UKTS going from normal
in the lower right corner to varying degrees of cortical cataract.
The lens in the bottom left panel is the most severe.
Found at: doi:10.1371/journal.pgen.1000584.s005 (9.61 MB TIF)
Figure S6 Plots of linkage disequilibrium (LD) for EPHA2. Each
LD plot is based on correlation coefficient of LD (r2) in the
HapMap CEU (A), BDES (B), UKTS (C), and BMES (D) datasets.
Found at: doi:10.1371/journal.pgen.1000584.s006 (2.84 MB TIF)
Table S1 Exonic primers and their amplification conditions for
EPHA2 gene re-sequencing.
Found at: doi:10.1371/journal.pgen.1000584.s007 (0.05 MB
DOC)
Table S2 Completeness of SNP genotyping and other quality
metrics.
Found at: doi:10.1371/journal.pgen.1000584.s008 (0.07 MB
DOC)
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family data.
Found at: doi:10.1371/journal.pgen.1000584.s009 (0.14 MB
DOC)
Table S4 Single SNP association using ASSOC in the UKTS
family data.
Found at: doi:10.1371/journal.pgen.1000584.s010 (0.14 MB
DOC)
Table S5 Association results using PLINK in the BMES
unrelated data. (A) P values from single SNP association under
the dominant model. (B) P values from single SNP trend test for
the severe cases and controls with age at least 70 years in the
BMES. (C) Haplotype association for the binary and quantitative
cortical cataract trait in BMES.
Found at: doi:10.1371/journal.pgen.1000584.s011 (0.10 MB
DOC)
Table S6 Heterogeneity test and meta-analysis using METAL
(A to D). Three genetic models (Add: additive, Dom: dominant,
and Rec: recessive) were tested for each SNP. QE-P: P values
associated with the Q statistic; Zscore: Z-score from meta-analysis;
N: the total number of individuals in the meta-analysis; Meta-P: P
values from meta-analysis. (A) Heterogeneity test (Q test) and
meta-analysis for the quantitative cortical cataract from the BDES
and UKTS. (B) Heterogeneity test (Q test) and meta-analysis for
severe cortical cataract from the BDES and UKTS. (C)
Heterogeneity test (Q test) and meta-analysis from all three
datasets (BDES, UKTS, and BMES) under the dominant model.
Found at: doi:10.1371/journal.pgen.1000584.s012 (0.23 MB
DOC)
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